Literature DB >> 23493420

Disparate individual fates compose robust CD8+ T cell immunity.

Veit R Buchholz1, Michael Flossdorf, Inge Hensel, Lorenz Kretschmer, Bianca Weissbrich, Patricia Gräf, Admar Verschoor, Matthias Schiemann, Thomas Höfer, Dirk H Busch.   

Abstract

A core feature of protective T cell responses to infection is the robust expansion and diversification of naïve antigen-specific T cell populations into short-lived effector and long-lived memory subsets. By means of in vivo fate mapping, we found a striking variability of immune responses derived from individual CD8(+) T cells and show that robust acute and recall immunity requires the initial recruitment of multiple precursors. Unbiased mathematical modeling identifies the random integration of multiple differentiation and division events as the driving force behind this variability. Within this probabilistic framework, cell fate is specified along a linear developmental path that progresses from slowly proliferating long-lived to rapidly expanding short-lived subsets. These data provide insights into how complex biological systems implement stochastic processes to guarantee robust outcomes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23493420     DOI: 10.1126/science.1235454

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  172 in total

Review 1.  Molecular regulation of effector and memory T cell differentiation.

Authors:  John T Chang; E John Wherry; Ananda W Goldrath
Journal:  Nat Immunol       Date:  2014-12       Impact factor: 25.606

Review 2.  Sizing up the key determinants of the CD8(+) T cell response.

Authors:  David C Tscharke; Nathan P Croft; Peter C Doherty; Nicole L La Gruta
Journal:  Nat Rev Immunol       Date:  2015-10-09       Impact factor: 53.106

3.  CD8(+) T cell diversification by asymmetric cell division.

Authors:  Michael Flossdorf; Jens Rössler; Veit R Buchholz; Dirk H Busch; Thomas Höfer
Journal:  Nat Immunol       Date:  2015-09       Impact factor: 25.606

Review 4.  Clonal expansion under the microscope: studying lymphocyte activation and differentiation using live-cell imaging.

Authors:  Michal Polonsky; Benjamin Chain; Nir Friedman
Journal:  Immunol Cell Biol       Date:  2015-12-22       Impact factor: 5.126

Review 5.  The memory of a killer T cell: models of CD8(+) T cell differentiation.

Authors:  Bram Gerritsen; Aridaman Pandit
Journal:  Immunol Cell Biol       Date:  2015-12-24       Impact factor: 5.126

6.  Inferring average generation via division-linked labeling.

Authors:  Tom S Weber; Leïla Perié; Ken R Duffy
Journal:  J Math Biol       Date:  2016-01-05       Impact factor: 2.259

7.  Linking the T cell receptor to the single cell transcriptome in antigen-specific human T cells.

Authors:  Auda A Eltahla; Simone Rizzetto; Mehdi R Pirozyan; Brigid D Betz-Stablein; Vanessa Venturi; Katherine Kedzierska; Andrew R Lloyd; Rowena A Bull; Fabio Luciani
Journal:  Immunol Cell Biol       Date:  2016-02-10       Impact factor: 5.126

8.  Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy.

Authors:  Christopher A Klebanoff; Joseph G Crompton; Anthony J Leonardi; Tori N Yamamoto; Smita S Chandran; Robert L Eil; Madhusudhanan Sukumar; Suman K Vodnala; Jinhui Hu; Yun Ji; David Clever; Mary A Black; Devikala Gurusamy; Michael J Kruhlak; Ping Jin; David F Stroncek; Luca Gattinoni; Steven A Feldman; Nicholas P Restifo
Journal:  JCI Insight       Date:  2017-12-07

Review 9.  Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells.

Authors:  Michael C Jensen; Stanley R Riddell
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

10.  Engineering human peripheral blood stem cell grafts that are depleted of naïve T cells and retain functional pathogen-specific memory T cells.

Authors:  Marie Bleakley; Shelly Heimfeld; Lori A Jones; Cameron Turtle; Diane Krause; Stanley R Riddell; Warren Shlomchik
Journal:  Biol Blood Marrow Transplant       Date:  2014-02-11       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.